Cite
HARVARD Citation
Papp, K. et al. (2016). A prospective phase III, randomized, double‐blind, placebo‐controlled study of brodalumab in patients with moderate‐to‐severe plaque psoriasis4. British journal of dermatology. pp. 273-286. [Online].